FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1997966308> ?p ?o ?g. }

• W1997966308 endingPage "515" @default.
• W1997966308 startingPage "503" @default.
• W1997966308 abstract "Reactivators of organophosphate (OP)-inhibited cholinesterases (ChEs) are believed to give rise to phosphorylated oximes (POX) that reinhibit the enzyme. Diethylphosphoryl oximes (DEP-OX) that were generated in situ were demonstrated in the past to be unstable, yet were more potent inhibitors of acetylcholinesterase (AChE) than the parent OPs. In view of the inconsistencies among reported results, and the potential toxicity of POXs, it seemed important to characterize authentic DEP-OXs, and to evaluate their interference with reactivation of diethylphosphoryl-ChE (DEP-ChE) conjugates. To this end, the diethylphosphoric acid esters of 1-methyl-2-pyridinium carboxaldehyde oxime (DEP-2PAM) and 1-methyl-4 pyridinium carboxaldehyde oxime (DEP-4PAM) were synthesized and chemically defined. The half-lives of DEP-2PAM and DEP-4PAM in 10 mM Tris buffer, pH 7.8, at 29 degrees were found to be 10 and 980 sec, respectively. The two DEP-OXs inhibited ChEs with the following ranking order: for DEP-2PAM, human butyrylcholinesterase (HuBChE, k(i) = 2.03 x 10(9) M(-1) min(-1)) > mouse AChE (MoAChE) approximately equal to fetal bovine serum AChE (FBS-AChE) approximately equal to equine BChE (EqBChE); for DEP-4PAM, HuBChE (k(i) = 0.71 x 10(9) M(-1) min(-1)) > EqBChE > MoAChE > FBS-AChE. A dialkylarylphosphate hydrolase (phosphotriesterase; PTE) from Pseudomonas sp. catalyzed the hydrolysis of DEP-4PAM with k(cat)/Km = 3.56 x 10(7) M(-1) min(-1) and Km = 0.78 mM. Reactivation of DEP-ChEs was enhanced by PTE when 4-PAM-based oximes were used as reactivators, whereas reactivation with 2-PAM-based oximes was not affected by PTE. This observation is attributed primarily to the short half-life of DEP-OXs derived from the latter oximes. Relatively low doses of PTE can detoxify large quantities of DEP-OXs rapidly, and thereby augment the efficacy of antidotes that contain the oxime function in position 4 of the pyridine ring." @default.
• W1997966308 created "2016-06-24" @default.
• W1997966308 creator A5026288465 @default.
• W1997966308 creator A5037125541 @default.
• W1997966308 creator A5038588827 @default.
• W1997966308 creator A5042020871 @default.
• W1997966308 creator A5052531545 @default.
• W1997966308 creator A5086549633 @default.
• W1997966308 date "1999-08-01" @default.
• W1997966308 modified "2023-09-29" @default.
• W1997966308 title "Characterization of O,O-diethylphosphoryl oximes as inhibitors of cholinesterases and substrates of phosphotriesterases" @default.
• W1997966308 cites W1501876632 @default.
• W1997966308 cites W1528949927 @default.
• W1997966308 cites W1729514393 @default.
• W1997966308 cites W1813976308 @default.
• W1997966308 cites W1963775291 @default.
• W1997966308 cites W1971048984 @default.
• W1997966308 cites W1979572414 @default.
• W1997966308 cites W1986937010 @default.
• W1997966308 cites W1990728675 @default.
• W1997966308 cites W2002859575 @default.
• W1997966308 cites W2010381620 @default.
• W1997966308 cites W2011323090 @default.
• W1997966308 cites W2012356623 @default.
• W1997966308 cites W2021704864 @default.
• W1997966308 cites W2023662389 @default.
• W1997966308 cites W2032782582 @default.
• W1997966308 cites W2032870060 @default.
• W1997966308 cites W2036381025 @default.
• W1997966308 cites W2037970345 @default.
• W1997966308 cites W2061103215 @default.
• W1997966308 cites W2061277918 @default.
• W1997966308 cites W2065756285 @default.
• W1997966308 cites W2072825448 @default.
• W1997966308 cites W2076166567 @default.
• W1997966308 cites W2076494228 @default.
• W1997966308 cites W2082971345 @default.
• W1997966308 cites W2086761657 @default.
• W1997966308 cites W2108174378 @default.
• W1997966308 cites W2109385147 @default.
• W1997966308 cites W2164320858 @default.
• W1997966308 cites W2170932573 @default.
• W1997966308 cites W2327602300 @default.
• W1997966308 cites W2332091266 @default.
• W1997966308 cites W3026491722 @default.
• W1997966308 doi "https://doi.org/10.1016/s0006-2952(99)00117-3" @default.
• W1997966308 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10424771" @default.
• W1997966308 hasPublicationYear "1999" @default.
• W1997966308 type Work @default.
• W1997966308 sameAs 1997966308 @default.
• W1997966308 citedByCount "35" @default.
• W1997966308 countsByYear W19979663082012 @default.
• W1997966308 countsByYear W19979663082015 @default.
• W1997966308 countsByYear W19979663082018 @default.
• W1997966308 countsByYear W19979663082020 @default.
• W1997966308 crossrefType "journal-article" @default.
• W1997966308 hasAuthorship W1997966308A5026288465 @default.
• W1997966308 hasAuthorship W1997966308A5037125541 @default.
• W1997966308 hasAuthorship W1997966308A5038588827 @default.
• W1997966308 hasAuthorship W1997966308A5042020871 @default.
• W1997966308 hasAuthorship W1997966308A5052531545 @default.
• W1997966308 hasAuthorship W1997966308A5086549633 @default.
• W1997966308 hasConcept C155647269 @default.
• W1997966308 hasConcept C161176658 @default.
• W1997966308 hasConcept C181199279 @default.
• W1997966308 hasConcept C185592680 @default.
• W1997966308 hasConcept C2776588719 @default.
• W1997966308 hasConcept C2777221202 @default.
• W1997966308 hasConcept C2778816929 @default.
• W1997966308 hasConcept C2779059548 @default.
• W1997966308 hasConcept C2779101902 @default.
• W1997966308 hasConcept C2779648554 @default.
• W1997966308 hasConcept C31896038 @default.
• W1997966308 hasConcept C55493867 @default.
• W1997966308 hasConcept C6557445 @default.
• W1997966308 hasConcept C71240020 @default.
• W1997966308 hasConcept C71924100 @default.
• W1997966308 hasConcept C86803240 @default.
• W1997966308 hasConcept C94412978 @default.
• W1997966308 hasConcept C98274493 @default.
• W1997966308 hasConceptScore W1997966308C155647269 @default.
• W1997966308 hasConceptScore W1997966308C161176658 @default.
• W1997966308 hasConceptScore W1997966308C181199279 @default.
• W1997966308 hasConceptScore W1997966308C185592680 @default.
• W1997966308 hasConceptScore W1997966308C2776588719 @default.
• W1997966308 hasConceptScore W1997966308C2777221202 @default.
• W1997966308 hasConceptScore W1997966308C2778816929 @default.
• W1997966308 hasConceptScore W1997966308C2779059548 @default.
• W1997966308 hasConceptScore W1997966308C2779101902 @default.
• W1997966308 hasConceptScore W1997966308C2779648554 @default.
• W1997966308 hasConceptScore W1997966308C31896038 @default.
• W1997966308 hasConceptScore W1997966308C55493867 @default.
• W1997966308 hasConceptScore W1997966308C6557445 @default.
• W1997966308 hasConceptScore W1997966308C71240020 @default.
• W1997966308 hasConceptScore W1997966308C71924100 @default.
• W1997966308 hasConceptScore W1997966308C86803240 @default.
• W1997966308 hasConceptScore W1997966308C94412978 @default.
• W1997966308 hasConceptScore W1997966308C98274493 @default.

• next